Veterinary Dietary Supplements Market (By Animal Type: Livestock Animals, Companion Animals; By Application: Joint Health Support, Calming/ Stress/ Anxiety, Digestive Health, Energy and Electrolytes, Immunity Support, Skin & Coat Health; By Type: Omega 3 Fatty Acids, Proteins & Peptides, CBD, Multivitamins & Minerals, Probiotics & Prebiotics, Others; By Dosage Form: Tablets & Capsules, Gummies & Chewables, Powders, Liquids, Others; By Distribution Channel: Online/ E-commerce, Offline) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Dietary Supplements Market, By Animal Type

7.1.  Veterinary Dietary Supplements Market, by Animal Type, 2020-2030

7.1.1.    Livestock Animals

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Companion Animals

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Veterinary Dietary Supplements Market, By Application

8.1.  Veterinary Dietary Supplements Market, by Application, 2020-2030

8.1.1.    Joint Health Support

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Calming/ Stress/ Anxiety

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Digestive Health

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Energy and Electrolytes

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Immunity Support

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Skin & Coat Health

8.1.6.1.        Market Revenue and Forecast (2016-2030)

8.1.7.    Others (Kidney, Urinary Tract, Liver, Cardiovascular, Weight Management)

8.1.7.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Veterinary Dietary Supplements Market, By Type

9.1.  Veterinary Dietary Supplements Market, by Type, 2020-2030

9.1.1.    Omega 3 Fatty Acids

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Proteins & Peptides

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    CBD

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Multivitamins & Minerals

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Probiotics & Prebiotics

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Others (Antioxidants)

9.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Veterinary Dietary Supplements Market, By Dosage Form

10.1.        Veterinary Dietary Supplements Market, by Dosage Form, 2020-2030

10.1.1.  Tablets & Capsules

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Gummies & Chewables

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Powders

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Liquids

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Others (Injectables, Paste)

10.1.5.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Veterinary Dietary Supplements Market, By Distribution Channel

11.1.        Veterinary Dietary Supplements Market, by Distribution Channel, 2020-2030

11.1.1.  Online/ E-commerce

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Offline

11.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Veterinary Dietary Supplements  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.1.2.  Market Revenue and Forecast, by Application (2016-2030)

12.1.3.  Market Revenue and Forecast, by Type (2016-2030)

12.1.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.1.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.1.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.1.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.1.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.1.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.1.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.1.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.1.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.1.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.2.  Market Revenue and Forecast, by Application (2016-2030)

12.2.3.  Market Revenue and Forecast, by Type (2016-2030)

12.2.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.8.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.8.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.8.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.9.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.9.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.9.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.2.  Market Revenue and Forecast, by Application (2016-2030)

12.3.3.  Market Revenue and Forecast, by Type (2016-2030)

12.3.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.8.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.8.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.8.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.9.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.9.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.9.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.2.  Market Revenue and Forecast, by Application (2016-2030)

12.4.3.  Market Revenue and Forecast, by Type (2016-2030)

12.4.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.8.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.8.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.8.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.9.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.9.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.9.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.5.2.  Market Revenue and Forecast, by Application (2016-2030)

12.5.3.  Market Revenue and Forecast, by Type (2016-2030)

12.5.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.5.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.5.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.5.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.5.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.5.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.5.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.5.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.5.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.5.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

Chapter 13.  Company Profiles

13.1.              Virbac

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Ark Naturals Company

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Beaphar

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              FoodScience

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              NOW Foods

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Nutramax Laboratories, Inc.

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Nutri-Pet Research, Inc.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Ceva

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Canna Companion

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Nestle

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms